Kukje Pharma Co Ltd Cash Flow Quality Index
Kukje Pharma Co Ltd cash flow quality index. Kukje Pharma Co Ltd (002720) has a Cash Flow Quality Index of 2.61x as of September 2025. Operating cash flow of ₩4.99 Billion exceeds net income of ₩1.91 Billion, indicating high earnings quality where cash backs reported profits. See Kukje Pharma Co Ltd leverage flexibility ratio to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Kukje Pharma Co Ltd (2011–2024)
Cash flow quality index of Kukje Pharma Co Ltd from 2011 to 2024. Historical Cash Flow Quality Index for Kukje Pharma Co Ltd across 8 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore debt repayment capacity of Kukje Pharma Co Ltd to assess how comfortably operating cash covers total debt obligations.
Kukje Pharma Co Ltd Cash Flow Quality Index by Year (2011–2024)
Kukje Pharma Co Ltd cash flow quality index by year from 2011 to 2024. Year-by-year earnings quality comparison for Kukje Pharma Co Ltd. For the full cash flow conversion analysis, see Kukje Pharma Co Ltd cash flow conversion.
| Year | Quality Index | Operating CF (KRW) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 0.76x | ₩3.94 Billion | ₩5.21 Billion | ▼ -58.6% |
| 2022 | 1.83x | ₩6.50 Billion | ₩3.56 Billion | ▼ -21.0% |
| 2020 | 2.32x | ₩5.10 Billion | ₩2.20 Billion | ▼ -61.7% |
| 2018 | 6.04x | ₩13.25 Billion | ₩2.19 Billion | ▲ +739.6% |
| 2017 | 0.72x | ₩786.10 Million | ₩1.09 Billion | ▼ -96.5% |
| 2016 | 20.82x | ₩16.10 Billion | ₩773.06 Million | ▲ +857.6% |
| 2013 | -2.75x | ₩-4.60 Billion | ₩1.67 Billion | ▼ -114.7% |
| 2011 | 18.74x | ₩17.39 Billion | ₩927.81 Million | — |